OMERS Administration Corp’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $33.8M | Buy |
134,479
+2,498
| +2% | +$537K | 0.2% | 93 |
|
|
2026
Q1 | $28.7M | Buy |
131,981
+25,306
| +24% | +$5.61M | 0.18% | 80 |
|
|
2025
Q4 | $24.4M | Buy |
106,675
+20,693
| +24% | +$4.71M | 0.17% | 62 |
|
|
2025
Q3 | $19.9M | Hold |
85,982
| – | – | 0.14% | 68 |
|
|
2025
Q2 | $16M | Sell |
85,982
-17,900
| -17% | -$3.33M | 0.13% | 74 |
|
|
2025
Q1 | $21.8M | Buy |
103,882
+25,409
| +32% | +$4.94M | 0.19% | 61 |
|
|
2024
Q4 | $13.9M | Buy |
78,473
+9,213
| +13% | +$1.69M | 0.12% | 76 |
|
|
2024
Q3 | $13.7M | Buy |
69,260
+1,400
| +2% | +$261K | 0.13% | 76 |
|
|
2024
Q2 | $11.6M | Buy |
+67,860
| New | +$11.2M | 0.11% | 85 |
|
|
2019
Q4 | – | Sell |
-138,000
| Closed | -$10.4M | – | 338 |
|
|
2019
Q3 | $10.4M | Buy |
138,000
+43,400
| +46% | +$2.98M | 0.1% | 99 |
|
|
2019
Q2 | $6.97M | Buy |
94,600
+88,200
| +1,378% | +$6.93M | 0.07% | 146 |
|
|
2019
Q1 | $534K | Buy |
+6,400
| New | +$524K | 0.01% | 280 |
|
|
2018
Q2 | – | Sell |
-51,900
| Closed | -$4.91M | – | 361 |
|
|
2018
Q1 | $4.91M | Sell |
51,900
-11,500
| -18% | -$1.26M | 0.05% | 176 |
|
|
2017
Q4 | $6.13M | Buy |
63,400
+18,700
| +42% | +$1.76M | 0.06% | 133 |
|
|
2017
Q3 | $3.97M | Buy |
44,700
+14,600
| +49% | +$1.11M | 0.04% | 139 |
|
|
2017
Q2 | $2.18M | Buy |
30,100
+20,500
| +214% | +$1.38M | 0.03% | 195 |
|
|
2017
Q1 | $626K | Hold |
9,600
| – | – | 0.01% | 229 |
|
|
2016
Q4 | $601K | Hold |
9,600
| – | – | 0.01% | 214 |
|
|
2016
Q3 | $605K | Hold |
9,600
| – | – | 0.01% | 445 |
|
|
2016
Q2 | $594K | Sell |
9,600
-47,500
| -83% | -$2.89M | 0.01% | 415 |
|
|
2016
Q1 | $3.26M | Sell |
57,100
-71,500
| -56% | -$3.99M | 0.07% | 164 |
|
|
2015
Q4 | $7.62M | Buy |
128,600
+6,600
| +5% | +$380K | 0.2% | 100 |
|
|
2015
Q3 | $6.64M | Buy |
122,000
+35,700
| +41% | +$2.32M | 0.19% | 111 |
|
|
2015
Q2 | $5.8M | Sell |
86,300
-113,200
| -57% | -$7.39M | 0.23% | 110 |
|
|
2015
Q1 | $11.7M | Buy |
199,500
+24,500
| +14% | +$1.48M | 0.44% | 64 |
|
|
2014
Q4 | $11.5M | Buy |
175,000
+153,100
| +699% | +$9.65M | 0.35% | 73 |
|
|
2014
Q3 | $1.26M | Hold |
21,900
| – | – | 0.04% | 213 |
|
|
2014
Q2 | $1.24M | Buy |
21,900
+6,700
| +44% | +$351K | 0.04% | 224 |
|
|
2014
Q1 | $781K | Buy |
15,200
+9,600
| +171% | +$485K | 0.03% | 240 |
|
|
2013
Q4 | $296K | Buy |
+5,600
| New | +$275K | 0.01% | 217 |
|
Other funds holding ABBV
OMERS Administration Corp's ABBV Position: Q2 2026 in Review
OMERS Administration Corp increased its AbbVie (ABBV) stake by 1.9% in Q2 2026, buying an estimated $537K and bringing the position to 134,479 shares worth $33.8M. The position accounts for 0.2% of the portfolio, ranked #93.
OMERS Administration Corp first reported a position in ABBV in Q4 2013 and has held it in 30 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- OMERS Administration Corp held 134,479 shares of AbbVie worth $33.8M as of Q2 2026.
- OMERS Administration Corp bought 2,498 AbbVie shares in Q2 2026, an estimated $537K.
- AbbVie made up 0.2% of OMERS Administration Corp's portfolio in Q2 2026, its #93 holding.
- OMERS Administration Corp first reported a position in AbbVie in Q4 2013 and has held it in 30 quarters since.
- 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.